Clinical Trials Browser

Phase 4 × INDUSTRY × enzalutamide × Clear all

NCT05457257 2025-12-19

Clinical Study to Assess the Efficacy and Safety of Olaparib in Chinese Patients With Metastatic Castration-Resistant Prostate Cancer Who Have Failed Prior Treatment With a New Hormonal Agent and Have BRCA1/2 Mutations

Phase 4 Completed

43 enrolled 16 charts

Metastatic Castration-resistant Prostate Cancer

NCT03641560 2025-04-08

A Safety and Efficacy Study of Enzalutamide in Indian Patients With Progressive Metastatic Castration-Resistant Prostate Cancer (mCRPC) Previously Treated With Docetaxel-Based Chemotherapy

Phase 4 Completed

52 enrolled 10 charts

Metastatic Castration Resistant Prostate Cancer

NCT02918968 2024-12-09

Study on Enzalutamide and Flutamide in Patients With Castration Resistant Prostate Cancer

Phase 4 Completed

206 enrolled 16 charts

Prostatic Neoplasms

NCT01977651 2024-12-06

UPWARD

Phase 4 Completed

424 enrolled 10 charts

Seizures

NCT02116582 2024-12-06

A Study to Evaluate Enzalutamide After Abiraterone in Metastatic Castration-Resistant Prostate Cancer

Phase 4 Completed

215 enrolled 11 charts

Metastatic Castration-Resistant Prostate Cancer

NCT01995513 2023-09-18

PLATO

Phase 4 Completed

509 enrolled 18 charts

Prostatic Neoplasms

NCT02485691 2022-05-27

CARD

Phase 4 Completed

255 enrolled 21 charts

Prostate Cancer Metastatic

NCT02441517 2018-04-19

A Study of Enzalutamide Re-treatment in Metastatic Castration-resistant Prostate Cancer After Docetaxel and/or Cabazitaxel Treatment

Phase 4 Terminated

4 enrolled 12 charts

Neoplasm Metastasis, Prostatic Neoplasms